Champions Oncology (CSBR) Other Accumulated Expenses (2021 - 2026)

Champions Oncology's Other Accumulated Expenses history runs 6 years deep, the most recent figure standing at $79000.0 for Q2 2026.

• In Q2 2026, Other Accumulated Expenses fell 41.48% year-over-year to $79000.0; the TTM figure through Apr 2026 stood at $79000.0 (down 41.48% YoY), while the FY2026 annual figure was $79000.0, down 41.48% from the prior year.
• Other Accumulated Expenses for Q2 2026 stood at $79000.0, up from $78000.0 in the prior quarter.
• The five-year high for Other Accumulated Expenses was $154000.0 in Q1 2025, with the low at $15000.0 in Q1 2022.
• The 5-year median for Other Accumulated Expenses is $143500.0 (2022), against an average of $123055.6.
• The sharpest annual moves came in 2023 and 2026: Other Accumulated Expenses jumped 860.0% in 2023, then slumped 49.35% in 2026.
• Champions Oncology's Other Accumulated Expenses stood at $143000.0 in 2022, then rose by 3.5% to $148000.0 in 2023, then climbed by 2.03% to $151000.0 in 2024, then tumbled by 35.76% to $97000.0 in 2025, then decreased by 18.56% to $79000.0 in 2026.
• Business Quant data shows CSBR's Other Accumulated Expenses at $79000.0 in Q2 2026, $78000.0 in Q1 2026, and $97000.0 in Q4 2025.